Meeting News and Highlights

VIDEO: Heart in Diabetes offers multidisciplinary view on cardiometabolic disorders

July 12, 2019 - 3rd HiD

VIDEO: Heart in Diabetes aims to address ‘avalanche of data’ on diabetes, CVD

July 16, 2019 - 3rd HiD

Annual Heart in Diabetes conference highlights intersection of diabetes, cardiovascular health, kidney disease

July 11, 2019 - 3rd HiD

VIDEO: ‘Cardiometabolic medicine’ proposed as new specialty

July 13, 2019 - 3rd HiD

Emerging Medical Management of Type 2 Diabetes in Older Adults

1/25/19 - With Yehuda Handelsman, MD, and Elena A. Christofides, MD

Diabetes and Heart Failure: Converging Conditions Require Greater Attention

July 26, 2018 - 2nd HiD

Jodi Godfrey, MS, RD

Diabetes and Cardiovascular Disease Impact Essentially Every Organ in the Body

July 27 - 2nd HiD

Jodi Godfrey, MS, RD

Cardiologists should consider prescribing GLP1 agents for CVD prevention in type 2 diabetes

July 15, 2018

Lifestyle changes necessary for mitigating cardiometabolic risk

July 15, 2018

Consumer technology poised to improve diabetes, CVD management"

July 14, 2018

Heart in Diabetes conference focuses on intersection of cardiometabolic specialties

July 13, 2018

Yehuda Handelsman 2018 Complete Interview​

June 12, 2018

Steve Freed,

R.PH., CDE

Diabetes and Heart Disease: 5 Lifestyle Fixes for Head-to-Toe Health

June 12, 2018

Jodi Godfrey, MS, RD

Hypertension in Diabetes: How Low to Go in Patients with Diabetes?

October 12, 2018 - 2nd HiD

Jodi Godfrey, MS, RD

Which Glucose-Lowering Drug Class—SGLT2i or GLP1RA—is Better for People with T2D and CVD?

SGLT2 Position

October 8, 2018 - 2nd HiD

Jodi Godfrey, MS, RD

Which Glucose-Lowering Drug Class—SGLT2i or GLP1RA—is Better for People with T2D and CVD?
GLP1RA Position

October 8, 2018 - 2nd HiD

Jodi Godfrey, MS, RD

18372 Clark St.

Suite 212

Tarzana, CA 91356

info@tmioa.com

Phone: 818-342-1889
Fax: 818-342-1538

  • Facebook
  • Twitter